查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1469267

全球骨科规划系统市场：依产品类型、最终用户、地区：产业分析、规模、占有率、成长、趋势、预测（2024-2031）

Orthopedic Planning Systems Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 380 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究提供了一份全面的报告，全面分析了骨科规划系统市场并详细介绍了其全球前景。这份详细的出版物提供了有关市场动态、趋势、机会和课题的宝贵见解，并对其结构进行了全面概述。在独特的数据和统计数据的支持下，本研究预测了 2024 年至 2031 年骨科规划系统市场的预期成长轨迹。

2024年，骨科规划系统的全球收入预计将达到8,615万美元，复合年增长率为7.9%，2031年将达到1.582亿美元。

重要见解

  • 骨科规划系统市场规模（2024年）：8,615万美元
  • 预计市场价值（2031 年）：1.582 亿美元
  • 全球市场成长率（2024-2032年复合年增长率）：7.9%

骨科规划系统市场-调查范围

全球整形外科规划系统市场为整形外科医生和医疗保健提供者提供了各种解决方案，以促进手术规划和植入物选择。主要驱动因素包括医疗技术的进步、骨科疾病盛行率的增加以及人口老化。新兴趋势包括个人化医疗和 3D 列印应用。总体而言，对高效外科手术、改善患者治疗效果以及对具有成本效益的医疗保健解决方案的需求不断增长正在推动市场发展。

市场驱动因素

骨科规划系统的日益普及是由几个相互关联的因素推动的，包括技术创新和对微创手术技术的接受度不断提高。影像模式和电脑辅助手术的进步正在提高手术精确度和病患安全，推动对骨科规划解决方案的需求。此外，人口老化和肥胖率上升等人口变化也导致骨科疾病盛行率上升，推动市场成长。随着医疗保健提供者努力优化治疗结果并儘量减少併发症，骨科规划系统在简化手术程序和加强患者护理方面发挥关键作用。

市场製约因素

骨科规划系统市场面临的课题包括监管障碍、报销限制和资料安全问题。遵守医疗设备和软体的严格监管要求给市场参与者带来了课题，需要在研发和监管合规方面进行大量投资。此外，报销政策因地区而异，影响骨科治疗计划系统的实施和提供者的决策。对资料安全和病患隐私的担忧也是市场成长的障碍，需要采取强有力的网路安全措施并遵守资料保护法规来保护病患资讯。

市场机会

骨科规划系统领域的市场成长机会包括新兴市场的应用扩展、技术进步和策略伙伴关係。新兴国家骨科疾病盛行率的上升、医疗基础设施的改善以及先进医疗技术的普及创造了市场扩张的机会。此外，3D 列印和人工智慧领域的持续创新为增强骨科规划系统的功能提供了机会，从而实现个人化治疗方法和优化手术结果。骨科设备製造商、软体开发商和医疗保健组织之间的合作促进了整合解决方案的开发，以满足骨科医生和患者不断变化的需求。

报告回答的关键问题

  • 推动骨科规划系统市场成长的关键因素是什么？
  • 塑造骨科规划系统市场的新兴趋势是什么？
  • 阻碍市场扩张的主要课题是什么？
  • 骨科规划系统领域的市场参与者有哪些机会？

目录

第一章内容提要

第二章市场概况

  • 市场范围/分类
  • 市场定义/范围/限制
  • 包容与排除

第 3 章主要市场趋势

  • 影响市场的主要趋势
  • 产品创新/发展趋势

第四章市场背景

  • 宏观经济因素
  • 预测器
  • 市场动态
  • 全球供需分析

第五章 新冠疫情危机分析

  • 目前的 COVID19 统计数据和未来潜在的影响
  • COVID19 与影响分析
    • 依溶液
    • 依用途
    • 展开类别
    • 依最终用户

第 6 章关键成功因素

  • 重大发展
  • 监管场景
  • 主要交易及合约
  • 依地区划分的手术数量

第七章全球骨科规划系统市场：价格分析

  • 依国家和地区划分的定价分析（依解决方案）
  • 价格细目
    • 製造商级定价
    • 经销商级定价
  • 全球平均价格分析基准

第八章全球骨科规划系统市场需求分析（2019-2023）与预测（2024-2031）

  • 2019-2023年历史市值分析
  • 当前和未来市场价值预测，2024-2031
    • 同比增长趋势分析
    • 绝对获利机会分析

第9章全球骨科规划系统市场分析（2019-2023）与预测（2024-2031）（依解法）

  • 简介/主要发现
  • 2019-2023 年历史市场规模分析（依解决方案）
  • 当前和未来的市场规模分析和预测（依解决方案），2024-2031 年
    • 骨科手术计划系统
      • 术前规划软体
        • 2D规划软体
        • 3D规划软体
      • 术后规划软体
  • 依解决方案进行市场吸引力分析

第10章全球骨科规划系统市场分析（2019-2023）与预测（2024-2031）（依应用）

  • 简介/主要发现
  • 过去的市场规模分析（依应用），2019-2023
  • 2024-2031 年当前和未来市场规模（依应用）分析和预测
    • 骨科
      • 关节置换手术
        • 髋关节置换术
        • 膝关节置换术
        • 肩关节置换术
        • 听骨置换
    • 骨科肿瘤学
  • 依应用划分的市场吸引力分析

第十一章全球骨科规划系统市场分析（2019-2023）与预测（2024-2031）（依发展）

  • 简介/主要发现
  • 过去的市场规模分析（依发展），2019-2023
  • 2024-2031 年当前和未来市场规模（依发展情况）分析和预测
    • 网路为基础的软体
    • 基于云的软件
    • 本地
  • 依发展划分的市场吸引力分析

第十二章全球骨科规划系统市场分析（2019-2023）与预测（2024-2031）（依最终使用者）

  • 简介/主要发现
  • 2019-2023 年历史市场规模分析（依最终用户）
  • 2024-2031 年最终用户当前和未来市场规模的分析和预测
    • 医院
    • 门诊手术中心
    • 骨科诊所基地
    • 诊所
  • 依最终用户划分的市场吸引力分析

第十三章依地区分列的全球骨科规划系统市场分析（2019-2023）和预测（2024-2031）

  • 介绍
  • 2019-2023 年历史市场规模分析（依地区）
  • 当前市场规模分析和预测（依地区），2024-2031
    • 北美
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚
    • 大洋洲
    • 中东和非洲 (MEA)
  • 依地区划分的市场吸引力分析

第14章北美骨科规划系统市场分析（2019-2023）与预测（2024-2031）

第十五章拉丁美洲骨科规划系统市场分析（2019-2023）与预测（2024-2031）

第十六章欧洲骨科规划系统市场分析（2019-2023）与预测（2024-2031）

第十七章南亚和太平洋地区骨科规划系统市场分析（2019-2023）和预测（2024-2031）

第十八章东亚骨科规划系统市场分析（2019-2023）与预测（2024-2031）

第十九章大洋洲骨科规划系统市场分析（2019-2023）与预测（2024-2031）

第20章中东和非洲骨科规划系统市场分析（2019-2023）和预测（2024-2031）

第21章主要全国骨科规划系统市场分析（2024-2031）

  • 介绍
    • 市值比率分析
    • 全球和国家成长比较
    • 依国家/地区的价格分析
  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 德国
  • 义大利
  • 法国
  • 英国
  • 西班牙
  • 俄罗斯
  • 中国
  • 日本
  • 韩国
  • 印度
  • 东盟
  • 澳大利亚
  • 纽西兰
  • 土耳其
  • 南非

第22章市场结构分析

  • 市场分析：依公司层级（骨科手术规划系统）
  • 主要参与者的市场占有率分析
  • 市场存在分析

第 23 章 竞争分析

  • 比赛仪表板
  • 竞争标桿
  • 竞争对手详情
    • Formus Labs Ltd
    • EOS imaging
    • Brainlab AG
    • Sectra AB
    • Stryker
    • Materialise
    • Medstrat
    • MediCAD Hectec GmbH
    • 3D Systems, Inc
    • PEEK HEALTH SA
    • Radlink, Inc.
    • SurgiNovi
    • RSA Biomedical
    • HIPOP-PLAN
    • Zimmer Biomet.
    • Optinav
    • Enhatch Inc.
    • Numex GmbH
    • Corin Group

第 24 章先决条件和使用的缩写词

第25章研究方法论

简介目录
Product Code: PMRREP26182

Persistence Market Research has conducted a thorough analysis of the Orthopedic Planning Systems Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Orthopedic Planning Systems Market spanning from 2024 to 2031.

In 2024, global revenue from orthopedic planning systems reached US$ 86.15 million, projected to grow at a CAGR of 7.9%, reaching US$ 158.2 million by 2031.

Key Insights:

  • Orthopedic Planning Systems Market Size (2024): US$ 86.15 Mn
  • Projected Market Value (2031): US$ 158.2 Mn
  • Global Market Growth Rate (2024-2031): 7.9% CAGR

Orthopedic Planning Systems Market - Report Scope

The global orthopedic planning systems market offers various solutions for orthopedic surgeons and healthcare providers, facilitating surgical planning and implant selection. Key drivers include advancements in medical technology, increasing prevalence of orthopedic disorders, and the growing aging population. Emerging trends focus on personalized medicine and 3D printing applications. Overall, the market is driven by the rising demand for efficient surgical procedures, improved patient outcomes, and the need for cost-effective healthcare solutions.

Market Growth Drivers

The expanding adoption of orthopedic planning systems is fueled by several interconnected factors, including technological innovation and the growing acceptance of minimally invasive surgical techniques. Advances in imaging modalities and computer-assisted surgery enhance surgical accuracy and patient safety, driving the demand for orthopedic planning solutions. Additionally, demographic shifts, such as an aging population and rising obesity rates, contribute to the increasing incidence of orthopedic conditions, boosting market growth. As healthcare providers strive to optimize treatment outcomes and minimize complications, orthopedic planning systems play a crucial role in streamlining surgical procedures and enhancing patient care.

Market Restraints

Challenges facing the orthopedic planning systems market include regulatory hurdles, reimbursement limitations, and data security concerns. Compliance with stringent regulatory requirements for medical devices and software poses challenges for market players, necessitating substantial investments in research and development and regulatory compliance efforts. Moreover, reimbursement policies vary across regions, impacting the adoption of orthopedic planning systems and healthcare provider decisions. Data security and patient privacy concerns also present barriers to market growth, requiring robust cybersecurity measures and compliance with data protection regulations to safeguard patient information.

Opportunities

Opportunities for market growth in the orthopedic planning systems segment include expanding applications in emerging markets, technological advancements, and strategic partnerships. The rising prevalence of orthopedic disorders in developing countries creates opportunities for market expansion, as healthcare infrastructure improves and access to advanced medical technologies increases. Furthermore, ongoing innovations in 3D printing and artificial intelligence offer opportunities to enhance the capabilities of orthopedic planning systems, enabling personalized treatment approaches and optimizing surgical outcomes. Collaborations between orthopedic device manufacturers, software developers, and healthcare institutions facilitate the development of integrated solutions that address the evolving needs of orthopedic surgeons and patients.

Key Questions Answered in Report::

  • What are the key drivers propelling the growth of the orthopedic planning systems market?
  • What emerging trends are shaping the landscape of orthopedic planning systems?
  • What are the primary challenges hindering market expansion, and how can they be mitigated?
  • What opportunities exist for market players to capitalize on in the orthopedic planning systems segment?

Competitive Intelligence and Business Strategy

In October 2020, EOS imaging installed its first EOSedge(TM) system at the Macquarie University Hospital in Australia, marking a significant milestone for the company in expanding its market presence.

In December 2020, Zimmer Biomet bolstered its product offerings by acquiring A&E Medical, gaining access to a diverse portfolio of sternal closure devices, including cable systems and sternal sutures.

In April 2020, Brainlab achieved CE Mark approval for its advanced patient positioning and monitoring system, ExacTrac(R) Dynamic, demonstrating its commitment to innovation and meeting regulatory standards.

Key Companies Profiled

  • Formus Labs Ltd,
  • EOS imaging,
  • Brainlab AG,
  • Sectra AB,
  • Stryker,
  • Materialise,
  • Medstrat,
  • mediCAD Hectec GmbH,
  • 3D Systems, Inc.,
  • PEEK HEALTH S.A,
  • Radlink, Inc.,
  • SurgiNovi,
  • RSA Biomedical,
  • HIPOP-PLAN,
  • Zimmer Biomet,
  • Optinav,
  • Enhatch Inc.,

Key Segments Covered in Orthopedic Planning Systems Industry Research

Orthopedic Planning Systems Market by Solution:

  • Pre-Surgical Planning Software

o2D Planning Software

o3D Planning Software

  • Post-Surgical Planning Software

Orthopedic Planning Systems Market by Application:

  • Joint Replacement

oHip Replacement

oKnee Replacement

oShoulder Replacement

oSmall Bone Replacement

  • Orthopaedic Oncology

Orthopedic Planning Systems Market by Deployment:

  • Web Based Software
  • Cloud Based Software
  • On Premises

Orthopedic Planning Systems Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopaedic Office-Based Clinics

Orthopedic Planning Systems Market by Region:

  • North America Orthopedic Planning Systems Market
  • Latin America Orthopedic Planning Systems Market
  • Europe Orthopedic Planning Systems Market
  • South Asia Orthopedic Planning Systems Market
  • East Asia Orthopedic Planning Systems Market
  • Oceania Orthopedic Planning Systems Market
  • Middle East & Africa Orthopedic Planning Systems Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Market Background

  • 4.1. Macro-Economic factors
    • 4.1.1. Global Healthcare Market Outlook
    • 4.1.2. Healthcare IT Spending Outlook, By U.S. & Global
    • 4.1.3. U.S. per-Capita Healthcare Expenditure
  • 4.2. Forecast Factors
    • 4.2.1. Evaluation of Incremental Costs and Effectiveness
    • 4.2.2. Increasing Spending on Healthcare Per Capita
    • 4.2.3. Increasing Spending for Healthcare Infrastructure Development Post COVID-19 Pandemic
    • 4.2.4. Application of biomedical and nanotechnology in Orthopaedics
  • 4.3. Market Dynamics
    • 4.3.1. Demand
    • 4.3.2. Restraints
    • 4.3.3. Opportunity
  • 4.4. Global Supply Demand Analysis

5. COVID19 Crisis Analysis

  • 5.1. Current COVID19 Statistics and Probable Future Impact
  • 5.2. COVID19 and Impact Analysis
    • 5.2.1. By Solution
    • 5.2.2. By Application
    • 5.2.3. By Deployment
    • 5.2.4. By End User

6. Key Success Factors

  • 6.1. Key Developments
  • 6.2. Regulatory Scenario
  • 6.3. Key Deals and Contracts
  • 6.4. Number of Surgeries, By Region

7. Global Orthopedic Planning Systems Market - Pricing Analysis

  • 7.1. Country-wise & Regional Pricing Analysis, By Solution
  • 7.2. Pricing Break-up
    • 7.2.1. Manufacturer Level Pricing
    • 7.2.2. Distributor Level Pricing
  • 7.3. Global Average Pricing Analysis Benchmark

8. Global Orthopedic Planning Systems Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2031

  • 8.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 8.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis

9. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Solution

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Solution, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Solution, 2024-2031
    • 9.3.1. Orthopedic Planning Systems
      • 9.3.1.1. Pre-Surgical Planning Software
        • 9.3.1.1.1. 2D Planning Software
        • 9.3.1.1.2. 3D Planning Software
      • 9.3.1.2. Post-Surgical Planning Software
  • 9.4. Market Attractiveness Analysis, By Solution

10. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 10.3.1. Orthopedic Surgery
      • 10.3.1.1. Joint Replacement
        • 10.3.1.1.1. Hip Replacement
        • 10.3.1.1.2. Knee Replacement
        • 10.3.1.1.3. Shoulder Replacement
        • 10.3.1.1.4. Small Bone Replacement
    • 10.3.2. Orthopedic Oncology
  • 10.4. Market Attractiveness Analysis, By Application

11. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Deployment

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Deployment, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Deployment, 2024-2031
    • 11.3.1. Web Based Software
    • 11.3.2. Cloud Based Software
    • 11.3.3. On Premises
  • 11.4. Market Attractiveness Analysis, By Deployment

12. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2031
    • 12.3.1. Hospitals
    • 12.3.2. Ambulatory Surgical Centres
    • 12.3.3. Orthopedic Office-Based
    • 12.3.4. Clinics
  • 12.4. Market Attractiveness Analysis, By End User

13. Global Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis, By Region

14. North America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 14.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Solution
    • 14.4.3. By Application
    • 14.4.4. By Deployment
    • 14.4.5. By End User
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Solution
    • 14.5.3. By Application
    • 14.5.4. By Deployment
    • 14.5.5. By End User
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. Latin America Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 15.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Mexico
      • 15.4.1.3. Rest of Latin America
    • 15.4.2. By Solution
    • 15.4.3. By Application
    • 15.4.4. By Deployment
    • 15.4.5. By End User
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Solution
    • 15.5.3. By Application
    • 15.5.4. By Deployment
    • 15.5.5. By End User
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Europe Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 16.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. Italy
      • 16.4.1.3. France
      • 16.4.1.4. U.K.
      • 16.4.1.5. Spain
      • 16.4.1.6. BENELUX
      • 16.4.1.7. Russia
      • 16.4.1.8. Rest of Europe
    • 16.4.2. By Solution
    • 16.4.3. By Application
    • 16.4.4. By Deployment
    • 16.4.5. By End User
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Solution
    • 16.5.3. By Application
    • 16.5.4. By Deployment
    • 16.5.5. By End User
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. South Asia and Pacific Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 17.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. ASEAN
      • 17.4.1.3. Oceania
      • 17.4.1.4. Rest of South Asia & Pacific
    • 17.4.2. By Solution
    • 17.4.3. By Application
    • 17.4.4. By Deployment
    • 17.4.5. By End User
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Solution
    • 17.5.3. By Application
    • 17.5.4. By Deployment
    • 17.5.5. By End User
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. East Asia Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 18.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Solution
    • 18.4.3. By Application
    • 18.4.4. By Deployment
    • 18.4.5. By End User
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Solution
    • 18.5.3. By Application
    • 18.5.4. By Deployment
    • 18.5.5. By End User
  • 18.6. Market Trends
  • 18.7. Key Market Participants - Intensity Mapping
  • 18.8. Drivers and Restraints - Impact Analysis

19. Oceania Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 19.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Solution
    • 19.4.3. By Application
    • 19.4.4. By Deployment
    • 19.4.5. By End User
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Solution
    • 19.5.3. By Application
    • 19.5.4. By Deployment
    • 19.5.5. By End User
  • 19.6. Market Trends
  • 19.7. Key Market Participants - Intensity Mapping
  • 19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Orthopedic Planning Systems Market Analysis 2019-2023 and Forecast 2024-2031

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Mn) Trend Analysis, By Market Taxonomy, 2019-2023
  • 20.4. Market Size (US$ Mn) Forecast, By Market Taxonomy, 2024-2031
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Turkey
      • 20.4.1.3. Northern Africa
      • 20.4.1.4. South Africa
      • 20.4.1.5. Rest of Middle East and Africa
    • 20.4.2. By Solution
    • 20.4.3. By Application
    • 20.4.4. By Deployment
    • 20.4.5. By End User
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Solution
    • 20.5.3. By Application
    • 20.5.4. By Deployment
    • 20.5.5. By End User
  • 20.6. Market Trends
  • 20.7. Key Market Participants - Intensity Mapping
  • 20.8. Drivers and Restraints - Impact Analysis

21. Country Level Orthopedic Planning Systems Market Analysis 2024-2031

  • 21.1. Introduction
    • 21.1.1. Market Value Proportion Analysis
    • 21.1.2. Global VS. Country Growth Comparison
    • 21.1.3. Pricing Analysis, by Country
  • 21.2. U.S. Orthopedic Planning Systems Market Analysis
    • 21.2.1. By Solution
    • 21.2.2. By Application
    • 21.2.3. By Deployment
    • 21.2.4. By End User
  • 21.3. Canada Orthopedic Planning Systems Market Analysis
    • 21.3.1. By Solution
    • 21.3.2. By Application
    • 21.3.3. By Deployment
    • 21.3.4. By End User
  • 21.4. Mexico Orthopedic Planning Systems Market Analysis
    • 21.4.1. By Solution
    • 21.4.2. By Application
    • 21.4.3. By Deployment
    • 21.4.4. By End User
  • 21.5. Brazil Orthopedic Planning Systems Market Analysis
    • 21.5.1. By Solution
    • 21.5.2. By Application
    • 21.5.3. By Deployment
    • 21.5.4. By End User
  • 21.6. Germany Orthopedic Planning Systems Market Analysis
    • 21.6.1. By Solution
    • 21.6.2. By Application
    • 21.6.3. By Deployment
    • 21.6.4. By End User
  • 21.7. Italy Orthopedic Planning Systems Market Analysis
    • 21.7.1. By Solution
    • 21.7.2. By Application
    • 21.7.3. By Deployment
    • 21.7.4. By End User
  • 21.8. France Orthopedic Planning Systems Market Analysis
    • 21.8.1. By Solution
    • 21.8.2. By Application
    • 21.8.3. By Deployment
    • 21.8.4. By End User
  • 21.9. U.K. Orthopedic Planning Systems Market Analysis
    • 21.9.1. By Solution
    • 21.9.2. By Application
    • 21.9.3. By Deployment
    • 21.9.4. By End User
  • 21.10. Spain Orthopedic Planning Systems Market Analysis
    • 21.10.1. By Solution
    • 21.10.2. By Application
    • 21.10.3. By Deployment
    • 21.10.4. By End User
  • 21.11. Russia Orthopedic Planning Systems Market Analysis
    • 21.11.1. By Solution
    • 21.11.2. By Application
    • 21.11.3. By Deployment
    • 21.11.4. By End User
  • 21.12. China Orthopedic Planning Systems Market Analysis
    • 21.12.1. By Solution
    • 21.12.2. By Application
    • 21.12.3. By Deployment
    • 21.12.4. By End User
  • 21.13. Japan Orthopedic Planning Systems Market Analysis
    • 21.13.1. By Solution
    • 21.13.2. By Application
    • 21.13.3. By Deployment
    • 21.13.4. By End User
  • 21.14. S. Korea Orthopedic Planning Systems Market Analysis
    • 21.14.1. By Solution
    • 21.14.2. By Application
    • 21.14.3. By Deployment
    • 21.14.4. By End User
  • 21.15. India Orthopedic Planning Systems Market Analysis
    • 21.15.1. By Solution
    • 21.15.2. By Application
    • 21.15.3. By Deployment
    • 21.15.4. By End User
  • 21.16. ASEAN Orthopedic Planning Systems Market Analysis
    • 21.16.1. By Solution
    • 21.16.2. By Application
    • 21.16.3. By Deployment
    • 21.16.4. By End User
  • 21.17. Australia Orthopedic Planning Systems Market Analysis
    • 21.17.1. By Solution
    • 21.17.2. By Application
    • 21.17.3. By Deployment
    • 21.17.4. By End User
  • 21.18. New Zealand Orthopedic Planning Systems Market Analysis
    • 21.18.1. By Solution
    • 21.18.2. By Application
    • 21.18.3. By Deployment
    • 21.18.4. By End User
  • 21.19. Turkey Orthopedic Planning Systems Market Analysis
    • 21.19.1. By Solution
    • 21.19.2. By Application
    • 21.19.3. By Deployment
    • 21.19.4. By End User
  • 21.20. South Africa Orthopedic Planning Systems Market Analysis
    • 21.20.1. By Solution
    • 21.20.2. By Application
    • 21.20.3. By Deployment
    • 21.20.4. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis, By Tier of Companies (Orthopedic Planning Systems)
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis
    • 22.3.1. By Regional footprint of Players
    • 22.3.2. Device foot print by Players
    • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Benchmarking
  • 23.3. Competition Deep Dive
    • 23.3.1. Formus Labs Ltd
      • 23.3.1.1. Overview & Key financials
      • 23.3.1.2. Product Portfolio
      • 23.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.1.4. SWOT Analysis
      • 23.3.1.5. Sales Footprint
      • 23.3.1.6. Strategy Overview
      • 23.3.1.7. Sales and Marketing strategies
      • 23.3.1.8. Channel Strategies
    • 23.3.2. EOS imaging
      • 23.3.2.1. Overview & Key financials
      • 23.3.2.2. Product Portfolio
      • 23.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.2.4. SWOT Analysis
      • 23.3.2.5. Sales Footprint
      • 23.3.2.6. Strategy Overview
      • 23.3.2.7. Sales and Marketing strategies
      • 23.3.2.8. Channel Strategies
    • 23.3.3. Brainlab AG
      • 23.3.3.1. Overview & Key financials
      • 23.3.3.2. Product Portfolio
      • 23.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.3.4. SWOT Analysis
      • 23.3.3.5. Sales Footprint
      • 23.3.3.6. Strategy Overview
      • 23.3.3.7. Sales and Marketing strategies
      • 23.3.3.8. Channel Strategies
    • 23.3.4. Sectra AB
      • 23.3.4.1. Overview & Key financials
      • 23.3.4.2. Product Portfolio
      • 23.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.4.4. SWOT Analysis
      • 23.3.4.5. Sales Footprint
      • 23.3.4.6. Strategy Overview
      • 23.3.4.7. Sales and Marketing strategies
      • 23.3.4.8. Channel Strategies
    • 23.3.5. Stryker
      • 23.3.5.1. Overview & Key financials
      • 23.3.5.2. Product Portfolio
      • 23.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.5.4. SWOT Analysis
      • 23.3.5.5. Sales Footprint
      • 23.3.5.6. Strategy Overview
      • 23.3.5.7. Sales and Marketing strategies
      • 23.3.5.8. Channel Strategies
    • 23.3.6. Materialise
      • 23.3.6.1. Overview & Key financials
      • 23.3.6.2. Product Portfolio
      • 23.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.6.4. SWOT Analysis
      • 23.3.6.5. Sales Footprint
      • 23.3.6.6. Strategy Overview
      • 23.3.6.7. Sales and Marketing strategies
      • 23.3.6.8. Channel Strategies
    • 23.3.7. Medstrat
      • 23.3.7.1. Overview & Key financials
      • 23.3.7.2. Product Portfolio
      • 23.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.7.4. SWOT Analysis
      • 23.3.7.5. Sales Footprint
      • 23.3.7.6. Strategy Overview
      • 23.3.7.7. Sales and Marketing strategies
      • 23.3.7.8. Channel Strategies
    • 23.3.8. MediCAD Hectec GmbH
      • 23.3.8.1. Overview & Key financials
      • 23.3.8.2. Product Portfolio
      • 23.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.8.4. SWOT Analysis
      • 23.3.8.5. Sales Footprint
      • 23.3.8.6. Strategy Overview
      • 23.3.8.7. Sales and Marketing strategies
      • 23.3.8.8. Channel Strategies
    • 23.3.9. 3D Systems, Inc
      • 23.3.9.1. Overview & Key financials
      • 23.3.9.2. Product Portfolio
      • 23.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.9.4. SWOT Analysis
      • 23.3.9.5. Sales Footprint
      • 23.3.9.6. Strategy Overview
      • 23.3.9.7. Sales and Marketing strategies
      • 23.3.9.8. Channel Strategies
    • 23.3.10. PEEK HEALTH S.A
      • 23.3.10.1. Overview & Key financials
      • 23.3.10.2. Product Portfolio
      • 23.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.10.4. SWOT Analysis
      • 23.3.10.5. Sales Footprint
      • 23.3.10.6. Strategy Overview
      • 23.3.10.7. Sales and Marketing strategies
      • 23.3.10.8. Channel Strategies
    • 23.3.11. Radlink, Inc.
      • 23.3.11.1. Overview & Key financials
      • 23.3.11.2. Product Portfolio
      • 23.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.11.4. SWOT Analysis
      • 23.3.11.5. Sales Footprint
      • 23.3.11.6. Strategy Overview
      • 23.3.11.7. Sales and Marketing strategies
      • 23.3.11.8. Channel Strategies
    • 23.3.12. SurgiNovi
      • 23.3.12.1. Overview & Key financials
      • 23.3.12.2. Product Portfolio
      • 23.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.12.4. SWOT Analysis
      • 23.3.12.5. Sales Footprint
      • 23.3.12.6. Strategy Overview
      • 23.3.12.7. Sales and Marketing strategies
      • 23.3.12.8. Channel Strategies
    • 23.3.13. RSA Biomedical
      • 23.3.13.1. Overview & Key financials
      • 23.3.13.2. Product Portfolio
      • 23.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.13.4. SWOT Analysis
      • 23.3.13.5. Sales Footprint
      • 23.3.13.6. Strategy Overview
      • 23.3.13.7. Sales and Marketing strategies
      • 23.3.13.8. Channel Strategies
    • 23.3.14. HIPOP-PLAN
      • 23.3.14.1. Overview & Key financials
      • 23.3.14.2. Product Portfolio
      • 23.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.14.4. SWOT Analysis
      • 23.3.14.5. Sales Footprint
      • 23.3.14.6. Strategy Overview
      • 23.3.14.7. Sales and Marketing strategies
      • 23.3.14.8. Channel Strategies
    • 23.3.15. Zimmer Biomet.
      • 23.3.15.1. Overview & Key financials
      • 23.3.15.2. Product Portfolio
      • 23.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.15.4. SWOT Analysis
      • 23.3.15.5. Sales Footprint
      • 23.3.15.6. Strategy Overview
      • 23.3.15.7. Sales and Marketing strategies
      • 23.3.15.8. Channel Strategies
    • 23.3.16. Optinav
      • 23.3.16.1. Overview & Key financials
      • 23.3.16.2. Product Portfolio
      • 23.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.16.4. SWOT Analysis
      • 23.3.16.5. Sales Footprint
      • 23.3.16.6. Strategy Overview
      • 23.3.16.7. Sales and Marketing strategies
      • 23.3.16.8. Channel Strategies
    • 23.3.17. Enhatch Inc.
      • 23.3.17.1. Overview & Key financials
      • 23.3.17.2. Product Portfolio
      • 23.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.17.4. SWOT Analysis
      • 23.3.17.5. Sales Footprint
      • 23.3.17.6. Strategy Overview
      • 23.3.17.7. Sales and Marketing strategies
      • 23.3.17.8. Channel Strategies
    • 23.3.18. Numex GmbH
      • 23.3.18.1. Overview & Key financials
      • 23.3.18.2. Product Portfolio
      • 23.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.18.4. SWOT Analysis
      • 23.3.18.5. Sales Footprint
      • 23.3.18.6. Strategy Overview
      • 23.3.18.7. Sales and Marketing strategies
      • 23.3.18.8. Channel Strategies
    • 23.3.19. Corin Group
      • 23.3.19.1. Overview & Key financials
      • 23.3.19.2. Product Portfolio
      • 23.3.19.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.3.19.4. SWOT Analysis
      • 23.3.19.5. Sales Footprint
      • 23.3.19.6. Strategy Overview
      • 23.3.19.7. Sales and Marketing strategies
      • 23.3.19.8. Channel Strategies

24. Assumptions and Acronyms Used

25. Research Methodology